CEO Dirk Vollenbroich (2nd from left) and project partner lay the foundation for Minerva Biolabs´s novel production and administration building in Berlin, Germany, scheduled to host the company by end of 2018.

Move in November 2018, 2800 m² floor space, Berlin-Marzahn

International Quality Assurance Program for the detection of Mycoplasma applying nucleic acid amplification techniques.